Louis A. Cona M.D.
Oct 24, 2019
This post explains where we obtain our stem cells from, in detail.
The field of stem cell therapies can be difficult to navigate, as there is a plethora of questionable information about therapies, different kinds of stem cells, and research floating around the internet. It’s hard to tell exactly what therapies are being offered, what they can be used for, and more importantly, where the stem cells are coming from in the first place. The source and quality of the stem cells is of upmost importance to the safety of the patient and the effectiveness of a treatment. A therapy is no better than the cells used to administer it.
Currently, the most effective stem cell therapies for degenerative diseases and inflammation offered at DVC Stem are allogeneic treatments using cells sourced from ethically donated cord tissue. Although many clinics offer cord tissue-based treatments, not all clinics hold the same standard for sourcing and preparation of their cells. A clinic who will not share this information in detail should be a red flag to all potential patients. Cells used in treatments at DVC Stem start the preparation process at Vitro Biopharma in Golden, Colorado.
Vitro Biopharma only uses American Association of Tissue Bank (AATB) certified suppliers of full term (>36 weeks), donated human umbilical cords. The selection of these donated tissues is extremely regulated and strict. The cords are tested for STDs, Hep A/B/C/D, TB, Zika virus, no history of cancer or chronic illness, no history of auto-immune diseases, no tattoos or piercings, no travel abroad with one year, no history of CJD, negative for HIV, negative for HTLV 1 AND 2, and no history of drug or alcohol abuse. After the tissue is vigorously screened and accepted, Vitro then uses their clinical-grade and award-winning proprietary culture medium to expand the stem cells out to roughly 300 million cells per treatment.
Once the stem cells have been expanded to treatment-ready numbers, they still undergo quality control testing before release. Cells are rigorously tested for potency, blood-borne pathogens, contaminating agents, fungal presence, cellular ATP levels, and proper growth rates. The entire production process is completed in a certified sterile clean room, which must meet all regulations by the FDA, ISO, and CLIA. Additionally, all lab employees are required to be properly trained with documentation on file for review. All of these steps ensure the highest quality of output from Vitro Biopharma.Once the cells are ordered and ready for use, they are held in subzero cryo-storage, and shipped overnight to DVC Stem in the Cayman Islands for immediate use for a patient’s treatment.
Vitro Biopharma Inc. is a Colorado-based cellular laboratory and Winner of the Frost and Sullivan Cell Tools and Technologies Industry Technology Innovation Award. For more information on Vitro Biopharma Inc. and their CEO/Director, Dr. Jim Musick, visit their website at www.vitrobiopharma.com.
About the author
Dr. Cona has been performing stem cell therapy for over 10 years. He is a member of the World Academy of Anti-Aging Medicine (WAAAM). He is also a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians. He is the Medical Director for DVC Stem a world-renowned stem cell therapy clinic located in Grand Cayman.
Are you a candidate?
Complete our online application form to find out if you qualify for stem cell therapy.APPLY FOR TREATMENT
FOLLOW DVC STEM
Stromal vascular fraction explained by the experts at DVC Stem.
Read more ￫
Eddie "The Beast" Hall received an infusion of over 300 million cord tissue-derived mesenchymal stem cells at DVC Stem.
Read more ￫